Senior insider sale
AMNEAL PHARMACEUTICALS, INC. — senior position signals high conviction
$293.8K
32K shares
What this filing means
KIELY JOHN plans to sell 32K shares of AMNEAL PHARMACEUTICALS, INC. valued at approximately $293.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/27/2025ACC: 0002007317-25-000975
32K
Shares to sell
$293.8K
Approx. market value
32K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
EQUITY COMPENSATION
EQUITY COMPENSATION
5/10/2024
32KTotal acquired32K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/10/2024 | EQUITY COMPENSATION EQUITY COMPENSATION | 32K | — |
| Total | 32K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
32K
Market value
$293.8K
8/27/2025
Total
Units
32K
Value
$293.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/27/2025 | 32K | $293.8K | NASDAQ | Planned |
| Total | 32K | $293.8K | ||